八家杂志的编委：心理学报; Translational Psychiatry; Journal of Affective Disorder; Frontier in Psychiatry; Psychiatry Research; Plos One; Brazilian Journal of Psychiatry; Current Pharmaceutical Design

1. Lang X, Wang D, Chen D, Xiu M, Zhou H, Wang L, Cao B, Zhang XY. Association between hippocampal subfields and clinical symptoms of first-episode and drug naive schizophrenia patients during 12 weeks of risperidone treatment. Neurotherapeutics 2022. doi: 10.1007/s13311-021-01174-8.
2. Li XR, Xiu MH, Guan XN, Wang YC, Wang J, Leung E, Zhang XY. Altered antioxidant defenses in drug-naive first episode patients with schizophrenia are associated with poor treatment response to risperidone: 12-week results from a prospective longitudinal study. Neurotherapeutics. 2021 doi: 10.1007/s13311-021-01036-3.
3. Liu H, Liu H, Jiang S, Su L, Lu Y, Chen Z, Li X, Li X, Wang X, Xiu M, Zhang X. Sex-specific association between antioxidant defense system and therapeutic response to risperidone in schizophrenia: a prospective longitudinal study. Current Neuropharmacology 2021. doi: 0.2174/1570159X19666211111123918.
4. Liu H, Yu R, Gao Y, Li X, Guan X, Thomas K, Xiu M, Zhang X. Antioxidant enzymes and weight gain in drug-naive first episode schizophrenia patients treated with risperidone for 12 weeks: a prospective longitudinal study. Current Neuropharmacology 2021 doi: 10.2174/1570159X19666210920090547.
5.  Zhang XY, Yang M, Du X, Liao W, Chen D, Fan F, Xiu M, Jia Q, Ning Y, Huang X, Wu F, Soares JC, Cao B, Wang L, Chen H. Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug- naive schizophrenia. Molecular Psychiatry 2020;25(12):3220-3230
6. Cao B, Cho RY, Chen D, Xiu M, Wang L, Soares JC, Zhang XY. Treatment response prediction and individualized identification of first-episode drug-na？ve schizophrenia using brain functional connectivity. Molecular Psychiatry2020; 25(4):906-913
7.  Qu M, Wang J, Chen DC, Chen S, Xiu MH, Zhang XY. Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia. Free Radical and Biological Medicine 2020；160:887-893
8. Xiu MH, Li Z, Curbo ME, Wu HE, Chen DC, Chen S, Tong YS, Tan SP, Zhang XY.  Interrelationships between BDNF, superoxide dismutase and cognitive impairment in first episode drug-na？ve patients with schizophrenia. Schizophrenia Bulletin 2020; 46(6):1498-1510
9. Xiu MH, Guan HY, Zhao JM, Wang KQ, Pan YF, Su XR, Wang YH, Guo JM, Jiang L, Liu HY, Sun SG, Wu HR,  Liu XW, Yu HJ, Wei BC, Li XP, Trinh T, Tan SP, Zhang XY.  Cognitive enhancing effect of high-frequency neuronavigated rTMS in chronic schizophrenia patients with predominant negative symptoms: A double-blind controlled 32-week follow-up study. Schizophrenia Bulletin 2020; 46(5):1219-1230
10. Xia L, Liu L, Hong X, Wang D, Wei G, Wang J, Zhou H, Xu H, Tian Y, Dai Q, Wu HE, Chang C, Wang L, Kosten TR, Zhang XY. One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia. Neuropsychopharmacology 2020; 45(8):1362-1368
11. Wang DM, Zhang XY. Sex differences in the prevalence and clinical features of comorbid depressive symptoms in patients with never-treated, first-episode schizophrenia. The Lancet 2019; 394 (Supp.): S84
12.Chen DC, Yang KB, Nie Y, Wang N, Li YL, Xiu MH, He SC, Yang FD, Kosten TR, Soares JC, Zhang XY. Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships to clinical phenotypes and cognitive deficits. Psychological Medicine 2016; 46(15):3219-3230.
13. Xiu MH, Tian L, Chen S, Tan YL, Chen DC, Chen J. Chen N, Yang FD, Licinio J, Kosten TR. Soares JC, Zhang XY. Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia. Brain Behavior and Immunity 2016;57:116-124
14. Zhang XY, Tan YL, Chen DC, Tan SP, Yang FD, Wu HE, Zunta-Soares GB, Kosten TR, Huang XF, Soares JC. Interaction of BDNF with cytokines in chronic schizophrenia. Brain, Behavior and Immunity 2016; 51: 169-175
15. Zhang XY, Chen da C, Xiu MH, Yang FD, Tan YL, Luo X, Zuo L, Kosten TA, Kosten TR. Cognitive function, plasma manganese superoxide dismutase (MnSOD) and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls. Schizophrenia Bulletin 2014; 40(3): 592-601
16. Zhang XY, Chen da C, Xiu MH, Haile CN, Luo X, Zuo L, Kosten TA, Kosten TR. Cigarette smoking, psychopathology, and cognitive function in first-episode drug na？ve schizophrenia: a case-control study. Psychological Medicine 2013; 43(8):1651-1660.
17. Zhang XY, Tang W, Xiu MH, Chen DC, De Yang F, Tan YL, Wang ZR, Zhang F, Liu J, Liu L, Chen Y, Wen N, Kosten TR. Interleukin 18 and cognitive impairment in first episode and drug naive schizophrenia versus healthy controls. Brain Behavior and Immunity 2013; 32:105-111. 
18. Zhang XY, Liu L, Liu S, Hong X, Chen DC, Xiu MH, Kosten TA, Kosten TR. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia. The American Journal of Psychiatry 2012; 169：974-981
19. Zhang XY, Chen DC, Xiu MH, Haile CN, Zhang HP, Luo X, Xu K, Kosten TA, Kosten TR. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba. Biological Psychiatry 2012; 72: 700-706
20. Zhang XY, Tan YL, Zhou DF, Haile CN, Wu GY, Cao LY, Kosten TA, Kosten TR. Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology 32:2020-2024 (2007).
21. Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Haile CN, Kosten TA, Kosten TR. Nicotine dependence, symptoms, and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology 32 (9), 2020-2024, (2007)
22. Zhang XY, Kosten TA. Previous exposure to cocaine enhances cocaine self-administration in an alpha 1-adrenergic receptor dependent manner. Neuropsychopharmacology 32:638-645 (2007).
23. Zhang XY, Kosten TA. Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biological Psychiatry 57:1202-1024 (2005).
24. Zhang XY, Haile CN, Tan YL, Zuo LJ, Yang BZ, Cao LY, Zhou DF. Tumour necrosis factor alpha polymorphism (-1031T/C) is associated with age of onset of schizophrenia. Molecular Psychiatry 10:897-899 (2005).
25. Zhang XY, Zhou DF, Cao LY, Wu GY, Shen YC. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology 30:1532-1538 (2005).